Anshuman Panda

1.4k citations

24 papers · 844 indexed · h-index 10

Impact in

Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Cancer Research top 10%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Pulmonary and Respiratory Medicine 10
- Ferroptosis and cancer prognosis 4
- Gastric Cancer Management and Outcomes 4
Oncology 8
- Cancer Immunotherapy and Biomarkers 6

Co-authors: Shridar Ganesan (16 shared papers)Gyan Bhanot (14 shared papers)Mark N. Stein (5 shared papers)Aguirre A. de Cubas (3 shared papers)Kathryn E. Beckermann (3 shared papers)W. Kimryn Rathmell (4 shared papers)Jonathan S. Serody (2 shared papers)Christof C. Smith (2 shared papers)
Journals: Frontiers in Genetics (4 papers)Journal of Clinical Oncology (3 papers)Journal of Clinical Investigation (2 papers)JCI Insight (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: United States India Netherlands

In The Last Decade

Anshuman Panda

23 papers receiving 831 citations

Peers

Countries citing papers authored by Anshuman Panda

Since Specialization

Citations

This map shows the geographic impact of Anshuman Panda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anshuman Panda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anshuman Panda more than expected).

Fields of papers citing papers by Anshuman Panda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anshuman Panda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anshuman Panda. The network helps show where Anshuman Panda may publish in the future.

Co-authors

The 25 scholars most cited alongside Anshuman Panda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anshuman Panda Line = papers co-authored together Anshuman Panda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer Journal of Clinical Investigation ·Janice M. Mehnert, Anshuman Panda, Judy Zhong, Kim M. Hirshfield, Sherri Damare, Katherine Lane, Levi Sokol, Mark N. Stein, Lorna Rodriguez-Rodriquez, Howard L. Kaufman, Siraj M. Ali, Jeffrey S. Ross, Dean C. Pavlick, Gyan Bhanot, Eileen White, Robert S. DiPaola, Ann Lovell, Jonathan D. Cheng, Shridar Ganesan	2016	290
2	Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma Journal of Clinical Investigation ·Christof C. Smith, Kathryn E. Beckermann, Dante S. Bortone, Aguirre A. de Cubas, Lisa M. Bixby, Samuel Lee, Anshuman Panda, Shridar Ganesan, Gyan Bhanot, Eric Wallen, Matthew I. Milowsky, William Y. Kim, W. Kimryn Rathmell, Ronald Swanstrom, Joel S. Parker, Jonathan S. Serody, Sara R. Selitsky, Benjamin G. Vincent	2018	198
3	Endogenous retrovirus expression is associated with response to immune checkpoint pathway in clear cell renal cell carcinoma JCI Insight ·Anshuman Panda, Aguirre A. de Cubas, Mark N. Stein, Gregory Riedlinger, Joshua Kra, Tina Mayer, Christof C. Smith, Benjamin G. Vincent, Jonathan S. Serody, Kathryn E. Beckermann, Shridar Ganesan, Gyan Bhanot, W. Kimryn Rathmell	2018	118
4	Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors JCO Precision Oncology ·Anshuman Panda, Anil Malleshi Betigeri, Kalyanasundaram Subramanian, Jeffrey S. Ross, Dean C. Pavlick, Siraj M. Ali, Paul Markowski, Ann W. Silk, Howard L. Kaufman, Edmund C. Lattime, Janice M. Mehnert, Ryan J. Sullivan, Christine M. Lovly, Jeffrey A. Sosman, Douglas B. Johnson, Gyan Bhanot, Shridar Ganesan	2017	50
5	DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer JCI Insight ·Aguirre A. de Cubas, William Dunker, Andrew Zaninovich, Rachel A. Hongo, Anuj Bhatia, Anshuman Panda, Kathryn E. Beckermann, Gyan Bhanot, Shridar Ganesan, John Karijolich, W. Kimryn Rathmell	2020	46
6	Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma Scientific Reports ·Sunniva Bjørklund, Anshuman Panda, Surendra Kumar, Michael Seiler, Doug Robinson, Jinesh Gheeya, Yao Ming, Grethe I.G. Alnæs, Deborah Toppmeyer, Margit Riis, Bjørn Naume, Anne‐Lise Børresen‐Dale, Vessela N. Kristensen, Shridar Ganesan, Gyan Bhanot	2017	32
7	Genomic and immunologic correlates of LAG-3 expression in cancer OncoImmunology ·Anshuman Panda, Jeffrey Rosenfeld, Eric A. Singer, Gyan Bhanot, Shridar Ganesan	2020	29
8	Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples Nucleic Acids Research ·Anshuman Panda, Anupama Yadav, Huwate Yeerna, Amartya Singh, Michael Biehl, Markus Lux, Alexander Schulz, Tyler Klecha, Sebastian Doniach, Hossein Khiabanian, Shridar Ganesan, Pablo Tamayo, Gyan Bhanot	2020	19
9	SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis Oncogene ·Kevin Tong, Om A. Kothari, Katherine S. Haro, Anshuman Panda, Manisha Bandari, Jillian N. Carrick, Joseph J. Hur, Lanjing Zhang, Chang S. Chan, Jinchuan Xing, Michael L. Gatza, Shridar Ganesan, Michael P. Verzi	2021	17
10	Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer Frontiers in Genetics ·Anshuman Panda, Shridar Ganesan	2021	9
11	The Modular Adaptive Ribosome PLoS ONE ·Anupama Yadav, Aparna Radhakrishnan, Anshuman Panda, Amartya Singh, Himanshu Sinha, Gyan Bhanot	2016	8
12	A Modern Approach for Load Balancing Using Forest Optimization Algorithm Subasish Mohapatra, Ishan Aryendu, Anshuman Panda, Aswini Kumar Padhi	2018	5
13	Recurring Translocations in Barrett’s Esophageal Adenocarcinoma Frontiers in Genetics ·Manisha Bajpai, Anshuman Panda, Kristen Birudaraju, James Van Gurp, Amitabh Chak, Kiron M. Das, Parisa Javidian, Hana Aviv	2021	4
14	Barrett’s Epithelium to Esophageal Adenocarcinoma: Is There a “Point of No Return”? Frontiers in Genetics ·Anshuman Panda, Mi Ryung Shin, Christina Cheng, Manisha Bajpai	2021	3
15	A Gene Panel for Early Identification of Future Responders to Immune Checkpoint Blockade Frontiers in Genetics ·Anshuman Panda, Anil Malleshi Betigeri, Shridar Ganesan	2022	2
16	Abstract PR05: Exceptional Response to PD-1 antibody treatment in a POLE-mutant endometrial cancer Molecular Cancer Therapeutics ·Janice M. Mehnert, Anshuman Panda, H. Zhong, Kim M. Hirshfield, Sherri Damare, Katherine Stiles, Levi Sokol, Mark N. Stein, Lorna Rodríguez-Rodríguez, Howard L. Kaufman, Siraj M. Ali, Jeffrey S. Ross, Dean C. Pavlick, Gyan Bhanot, Eileen White, Robert S. DiPaola, Ann Lovell, Jonathan D. Cheng, Shridar Ganesan	2015	2
17	Expression of endogenous retroviruses and response to immune checkpoint therapy in renal cell cancer. Journal of Clinical Oncology ·Anshuman Panda, Aguirre De Cubas, Katy Beckermann, Gregory Riedlinger, Mark N. Stein, Tina Mayer, Janice M. Mehnert, W. Kimryn Rathmell, Gyan Bhanot, Shridar Ganesan	2018	2
18	Role for immune checkpoint blockade in BRCA2-mutant prostate cancer. Journal of Clinical Oncology ·Anshuman Panda, Mark N. Stein, Gregory Riedlinger, Gyan Bhanot, Shridar Ganesan	2019	2
19	Gene Expression in Barrett’s Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma Cancers ·Anshuman Panda, Gyan Bhanot, Shridar Ganesan, Manisha Bajpai	2021	2
20	Influence of GGBS on the Properties of Charge Chrome Based Geopolymer Concrete in Ambient Temperature SSRN Electronic Journal ·Sanghamitra Jena, Ramakanta Panigrahi, Anshuman Panda	2020	2

About Anshuman Panda

Anshuman Panda is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 24 papers that have together received 844 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers), Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (4 papers), Gastric Cancer Management and Outcomes (4 papers), RNA and protein synthesis mechanisms (3 papers), Immunotherapy and Immune Responses (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Oncology (424 citations), Cancer Research (215 citations), Obstetrics and Gynecology (84 citations), Immunology (215 citations) and Pulmonary and Respiratory Medicine (211 citations). Anshuman Panda has collaborated with scholars based in United States, India and Netherlands. Frequent co-authors include Shridar Ganesan, Gyan Bhanot, Mark N. Stein, Aguirre A. de Cubas, Kathryn E. Beckermann, W. Kimryn Rathmell, Jonathan S. Serody, Christof C. Smith, Benjamin G. Vincent and Howard L. Kaufman. Their work appears in journals such as Frontiers in Genetics, Journal of Clinical Oncology, Journal of Clinical Investigation, JCI Insight and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact